Activists demand Roche drops cost of vital breast cancer medicine

On Thursday 31st March, members of the Fix the Patent Laws campaign picketed outside pharmaceutical company Roche to highlight the excessive price of a life-saving breast cancer medicine. Women with a specific form of breast cancer, HER2 positive, require a medicine called trastuzumab (marketed in South Africa as Herceptin). Many women in South Africa who need trastuzumab cannot access it due to the high price charged by Roche. #RocheGreedKills

Related Articles